Recombinant Human Endostatin Combined With Envafolimab and Synchronal Radiochemotherapy
Clinical trial NCT06279754 · UNKNOWN
Trial details
- NCT number
- NCT06279754
- Sponsor
- The First Affiliated Hospital of Xinxiang Medical College
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-18
- Primary completion
- 2024-06-18
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.